110.82
+0.76
+(0.69%)
At close: April 17 at 6:28:11 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 16 | 17 |
| Avg. Estimate | 13.04B | 13.81B | 53.45B | 54.44B |
| Low Estimate | 12.86B | 13.55B | 52.11B | 50B |
| High Estimate | 13.18B | 14.24B | 55.86B | 58.33B |
| Year Ago Sales | 11.83B | 12.51B | 50.32B | 53.45B |
| Sales Growth (year/est) | 10.25% | 10.39% | 6.22% | 1.87% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0K9E.L | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Downgrade | UBS: Buy to Neutral | 2/13/2025 |
| Downgrade | Erste Group: Buy to Hold | 11/19/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 10/30/2024 |
| Downgrade | B of A Securities: Buy to Neutral | 9/11/2024 |
| Downgrade | Goldman Sachs: Buy to Neutral | 9/5/2024 |
| Downgrade | Jefferies: Buy to Hold | 9/3/2024 |